Lauren B. Krupp

Lauren B. Krupp

Auto-generated profile, based on publicly available information

Lauren B. Krupp

Pediatric MS Center, NYU Langone Health, New York, New York, USA

Research Focus & Metrics

Academic Career Length

51Years (1976-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 1989 in Archives of Neurology
Verified
Journal Article
Closed access
PDF file
LKLauren B. Krupp
Lauren B. Krupp
NLNicholas G. LaRocca
Nicholas G. LaRocca
JMJoanne Muir-Nash
Joanne Muir-Nash
ASAlfred D. Steinberg
Alfred D. Steinberg
From JAMA Neurology — The Fatigue Severity Scale — Application to Patients With Multiple Sclerosis and Systemic Lupus Erythematosus

9 April 2013 in Multiple Sclerosis Journal
Verified
Journal Article
Closed access
LKLauren B Krupp
Lauren B Krupp
MTMarc Tardieu
Marc Tardieu
MAMaria Pia Amato
Maria Pia Amato
BBBrenda Banwell
Brenda Banwell
TCTanuja Chitnis
Tanuja Chitnis
FGfor the International Pediatric Multiple Sclerosis Study Group
for the International Pediatric Multiple Sclerosis Study Group
Background: There has been tremendous growth in research in pediatric multiple sclerosis (MS) and immune mediated central nervous system demyelinating disorders since operational definitions for these conditions were first proposed in 2007. Further, the International Pediatric Multiple Sclerosis Study Group (IPMSSG), which proposed the criteria, has expanded substantially in membership and in its international scope. Objective: The purpose of this review is to revise the 2007 definitions in order to incorporate advances in delineating the clinical and neuroradiologic features of these disorders. Methods: Through a consensus process, in which input was sought from the 150 members of the Study Group, criteria were drafted, revised and finalized. Final approval was sought through a web survey. Results: Revised criteria are proposed for pediatric acute disseminated encephalomyelitis, pediatric clinically isolated syndrome, pediatric neuromyelitis optica and pediatric MS. These criteria were approved by 93% or more of the 56 Study Group members who responded to the final survey. Conclusions: These definitions are proposed for clinical and research purposes. Their utility will depend on the outcomes of their application in prospective research.

22 January 2013 in Neurology
Verified
Journal Article
Closed access
PDF file
BKBenzi M. Kluger
Benzi M. Kluger
LKLauren B. Krupp
Lauren B. Krupp
RERoger M. Enoka
Roger M. Enoka
Fatigue is commonly reported in many neurologic illnesses, including multiple sclerosis, Parkinson disease, myasthenia gravis, traumatic brain injury, and stroke. Fatigue contributes substantially to decrements in quality of life and disability in these illnesses. Despite the clear impact of fatigue as a disabling symptom, our understanding of fatigue pathophysiology is limited and current treatment options rarely lead to meaningful improvements in fatigue. Progress continues to be hampered by issues related to terminology and assessment. In this article, we propose a unified taxonomy and a novel assessment approach to addressing distinct aspects of fatigue and fatigability in clinical and research settings. This taxonomy is based on our current knowledge of the pathophysiology and phenomenology of fatigue and fatigability. Application of our approach indicates that the assessment and reporting of fatigue can be clarified and improved by utilizing this taxonomy and creating measures to address distinct aspects of fatigue and fatigability. We review the strengths and weaknesses of several common measures of fatigue and suggest, based on our model, that many research questions may be better addressed by using multiple measures. We also provide examples of how to apply and validate the taxonomy and suggest directions for future research.

1 April 1988 in Archives of Neurology
Verified
Journal Article
Closed access
PDF file
LKLauren B. Krupp
Lauren B. Krupp
LALuis A. Alvarez
Luis A. Alvarez
NLNicholas G. LaRocca
Nicholas G. LaRocca
LSLabe C. Scheinberg
Labe C. Scheinberg
Research from JAMA Neurology — Fatigue in Multiple Sclerosis

21 December 2011 in Multiple Sclerosis Journal
Verified
Journal Article
Open access
DLDawn Langdon
Dawn Langdon
MAMp Amato
Mp Amato
JBJ Boringa
J Boringa
BBB Brochet
B Brochet
FFF Foley
F Foley
RBRhb Benedict
Rhb Benedict
Background: Cognitive impairment in MS impacts negatively on many patients at all disease stages and in all subtypes. Full clinical cognitive assessment is expensive, requiring expert staff and special equipment. Test versions and normative data are not available for all languages and cultures. Objective: To recommend a brief cognitive assessment for multiple sclerosis (MS) that is optimized for small centers, with one or few staff members, who may not have neuropsychological training and constructed to maximize international use. Methods: An expert committee of twelve members representing the main cultural groups that have so far contributed considerable data about MS cognitive dysfunction was convened. Following exhaustive literature review, peer-reviewed articles were selected to cover a broad spectrum of cultures and scales that targeted cognitive domains vulnerable to MS. Each was rated by two committee members and candidates scales were rated on psychometric qualities (reliability, validity, and sensitivity), international application, ease of administration, feasibility in the specified context, and acceptability to patients. Results: The committee recommended the Symbol Digit Modalities Test, if only 5 minutes was available, with the addition of the California Verbal Learning Test – Second Edition and the Brief Visuospatial Memory Test – Revised learning trials if a further 10 minutes could be allocated for testing. Conclusions: A brief cognitive assessment for MS has been recommended. A validation protocol has been prepared for language groups and validation studies have commenced.

17 April 2007 in Neurology
Verified
Journal Article
Closed access
PDF file
LKLauren B. Krupp
Lauren B. Krupp
BBBrenda Banwell
Brenda Banwell
STSilvia Tenembaum
Silvia Tenembaum
FGfor the International Pediatric MS Study Group
for the International Pediatric MS Study Group
Background: The CNS inflammatory demyelinating disorders of childhood include both self-limited and lifelong conditions, which can be indistinguishable at the time of initial presentation. Clinical, biologic, and radiographic delineation of the various monophasic and chronic childhood demyelinating disorders requires an operational classification system to facilitate prospective research studies.